Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06819124 · ClinicalTrials.gov registry record · NA
Examining Interactions Between PALS and Caregivers
A NA study of Amyotrophic Lateral Sclerosis (ALS), sponsored by Penn State University.
- Recruiting
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT06819124: Recruiting NA study of Amyotrophic Lateral Sclerosis (ALS), sponsored by Penn State University.
NCT06819124 is a NA study of Amyotrophic Lateral Sclerosis (ALS) that is actively recruiting participants, run by Penn State University. The registered enrollment target is 152 participants, below the 294-participant average among 18 other Amyotrophic Lateral Sclerosis (ALS) trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06819124, a NA study of Amyotrophic Lateral Sclerosis (ALS), is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and their caregivers. The question is, What are the effects of communicative interaction on verbal communication in people with ALS when they interact with their caregivers and does this change over time? Participants will read words and sentences while they are interacting with their caregivers.
Primary Outcome
Formant frequencies that characterize speech sounds will be made on speech recorded in the intervention task.
Conditions Studied
Interventions
- BEHAVIORAL Structured Communicative Interaction
- BEHAVIORAL Unstructured communicative interaction
Study Locations (1)
Pennsylvania
- Speech Core, Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2025-01-22 |
| Est. Completion | 2029-02-28 |
| Phase | NA |
What NCT06819124 shows while recruiting
NCT06819124 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 294-participant average among 18 other Amyotrophic Lateral Sclerosis (ALS) trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Amyotrophic Lateral Sclerosis (ALS) appearing as the primary indexed condition, and to 2 interventions - of which Structured Communicative Interaction is the first listed.
NCT06819124 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06819124 about?
NCT06819124 is a clinical study titled "Examining Interactions Between PALS and Caregivers". The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and their caregivers. The question is, What are the effects of communicative interaction on verbal communication in people with ALS wh...
What is the current status of trial NCT06819124?
This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2025-01-22. Estimated completion is 2029-02-28.
What conditions does trial NCT06819124 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis (ALS).
What interventions are being tested in trial NCT06819124?
The interventions under investigation include: Structured Communicative Interaction (BEHAVIORAL), Unstructured communicative interaction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06819124?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06819124 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis (ALS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06819124's enrollment target sits among peer trials
152 6th of 18 higher than 13 of 18 other Amyotrophic Lateral Sclerosis (ALS) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis (ALS) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
RECRUITING · NA
-
Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis
COMPLETED · NA
-
Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS
COMPLETED · NA
-
Remotely Supervised tDCS for Slowing ALS Disease Progression
COMPLETED · NA
-
Healing ALS Registry Observational Study (HAROS)
RECRUITING
-
Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI